Related Experiment Video
Updated: Feb 3, 2026

Spotting Cheetahs: Identifying Individuals by Their Footprints
Published on: May 1, 2016
Clinical and biochemical footprints of primary mitochondrial disorders: proposed nosology
Martina Messina1, Rebecca Ganetzky2, Carlos R Ferreira3
1Mitochondrial Research Group, Genetics and Genomic Medicine Department, UCL Great Ormond Street Institute of Child Health, London, United Kingdom; Metabolic Department, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.
Abstract:
Primary mitochondrial diseases (PMD) are a growing number of disorders caused by mitochondrial dysfunction. There is not yet a consensus on the precise definition of PMD. Therefore, this study presents an approach to developing a nosology for standardized, systematic classification of PMD, harmonized with ICIMD and IEMbase. A total of 452 PMD causative genes were included. The classification includes 18 categories: 1) Disorders of amino acid metabolism; 2) Disorders of peptide and amine metabolism; 3) Disorders of carbohydrate metabolism; 4) Disorders of fatty acid and ketone body metabolism; 5) Disorders of energy substrate metabolism; 6) Mitochondrial DNA-related disorders; 7) Nuclear-encoded disorders of oxidative phosphorylation; 8) Disorders of mitochondrial cofactor biosynthesis; 9) Disorders of mitochondrial DNA maintenance and replication; 10) Disorders of mitochondrial gene expression; 11) Other disorders of mitochondrial function; 12) Disorders of metabolite repair/proofreading; 13) Disorders of lipid metabolism; 14) Disorders of nucleobase, nucleotide and nucleic acid metabolism; 15) Disorders of tetrapyrrole metabolism; 16) Disorders of organelle biogenesis, dynamics and interaction; 17) Disorders of vitamin and cofactor metabolism and 18) Neurotransmitter disorders. We also describe the clinical involvement of 22 organs and systems and laboratory features. The most prevalent symptoms (per gene) were neurological (21.1%), ocular (10.3%), muscular (9.0%), gastrointestinal (8.3%), and cardiovascular (7.9%).
Insights
This study introduces a standardized classification system for primary mitochondrial diseases (PMD), addressing the lack of a clear definition. It categorizes 452 genes and details clinical features, aiding in consistent diagnosis and research.
Area of Science:
- Genetics
- Biochemistry
- Medical Genetics
Background:
- Primary mitochondrial diseases (PMD) are a diverse group of disorders resulting from mitochondrial dysfunction.
- A lack of standardized definition and classification hinders research and clinical practice.
- Existing classifications lack harmonization with key databases like ICIMD and IEMbase.
Purpose of the Study:
- To develop a standardized nosology for the systematic classification of primary mitochondrial diseases.
- To harmonize the classification with existing international standards (ICIMD) and databases (IEMbase).
- To provide a comprehensive framework for categorizing PMD based on causative genes and affected metabolic pathways.
Main Methods:
- Compilation of 452 genes causative of primary mitochondrial diseases.
- Development of an 18-category classification system based on affected molecular functions and metabolic pathways.
- Analysis of clinical involvement across 22 organs and systems and common laboratory features.
Main Results:
- A novel 18-category classification system for PMD was established, covering metabolic, genetic, and functional aspects.
- The classification integrates 452 PMD-associated genes.
- Neurological, ocular, muscular, gastrointestinal, and cardiovascular systems were identified as the most frequently affected areas.
Conclusions:
- The proposed nosology provides a standardized and systematic approach to classifying primary mitochondrial diseases.
- This classification facilitates harmonization with ICIMD and IEMbase, improving consistency in diagnosis and research.
- Understanding the broad clinical spectrum and frequent organ involvement is crucial for managing PMD.
More Related Videos
Related Concept Videos
Animal Mitochondrial Genetics
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes
Intrinsically Disordered Proteins
Export of Mitochondrial and Chloroplast Genes
The Inner Mitochondrial Membrane
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

